Notice of Results

RNS Number : 2294S

EKF Diagnostics Holdings PLC

08 March 2019

 

EKF Diagnostics Holdings plc

("EKF", the "Company")

Notice of Results

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that it will release its preliminary results for the year ended 31 December 2018 on Wednesday 13 March 2019.

EKF Diagnostics Holdings plc	www.ekfdiagnostics.com
Christopher Mills, Non-Executive Chairman	Tel: [phone]
Julian Baines, CEO
Richard Evans, FD & COO
N+1 Singer (Nomad & Broker)	Tel: [phone]
Aubrey Powell / Lauren Kettle / George Tzimas (Corporate Finance) Tom Salvesen (Corporate Broking)
Walbrook PR Limited                                                                           Tel: [phone] or [e-mail]
Paul McManus/ Lianne Cawthorne	Mob: [phone]

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)

EKF is a leading point-of-care diagnostics and central laboratory assay manufacturer with an estimated 80,000 hemoglobin, hematocrit, HbA1c, glucose and lactate analyzers in regular use across more than 100 countries. EKF specializes in developing tests for use in anemia and diabetes diagnosis and management, as well as providing a portfolio of reagents for use in clinical chemistry analyzers.

 

END

 

 

NORFMGGFVNLGLZM